Pre-operative tachycardia is a frequent clinical manifestation commonly attributed to pain, anxiety, or systemic infection.1,2 However, uncommon endocrine emergencies such as pheochromocytoma may present with nonspecific cardiovascular instability and remain clinically unrecognized until catastrophic perioperative deterioration occurs.3,4 This case report describes a 26-year-old female who presented with a painful hyperemic right breast mass accompanied by persistent tachycardia and respiratory distress. In accordance with CARE case report principles, clinical data were retrospectively collected from medical records, including serial hemodynamic monitoring, laboratory investigations, electrocardiography, thoracic imaging, perioperative management, and intensive care interventions. Initial evaluation demonstrated persistent tachycardia (153 bpm), tachypnea, and hypertensive episodes that were disproportionate to the localized breast pathology. Despite surgical intervention and initial postoperative stabilization, the patient developed progressive hemodynamic instability characterized by persistent tachyarrhythmia, a Burch-Wartofsky Point Scale score of 20, severe hyperglycemia (858 mg/dL), ketonuria, and electrolyte imbalance, which eventually culminated in asystolic cardiac arrest. This constellation of cardiovascular and metabolic abnormalities strongly suggested a pheochromocytoma crisis precipitated by surgical stress and excessive catecholamine release.1,3,4 Catecholamine-induced insulin resistance and impaired peripheral glucose utilization likely contributed to the profound metabolic derangement observed in this patient.5,6 This case underscores the importance of recognizing unexplained perioperative tachycardia and hyperglycemia as potential indicators of occult pheochromocytoma.7–9 Early endocrine evaluation and appropriate perioperative preparation are critical to prevent fatal cardiovascular complications and improving surgical outcomes. DOI : 10.35990/amhs.v4n3.p151-158 REFERENCES Nazari MA, Rosenblum JS, Haigney MC, Rosing DR, Pacak K. Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 Jul 28;76(4):451–64. http://doi:10.1016/J.JACC.2020.04.080; PAGEGROUP:STRING PubMed PMID: 32703516. Kamath AS, Singh K. Perioperative Management of Pheochromocytoma. StatPearls. 2023 Jul 6. PubMed PMID: Meijs AC, Snel M, Corssmit EPM. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas. Hormones (Athens). 2021 Jun 1;20(2):395–403. http://doi:10.1007/S42000-021-00274-6 PubMed PMID: 33575936. Whitelaw BC, Prague JK, Mustafa OG, Schulte KM, Hopkins PA, Gilbert JA, et al. Phaeochromcytoma crisis. Clin Endocrinol (Oxf). 2014 Jan;80(1):13–22. http://doi:10.1111/CEN.12324 PubMed PMID: 24102156. Zhou Y, Tai Y, Shang J. Progress in treatment and follow-up of pheochromocytoma. European Journal of Surgical Oncology. W.B. Saunders Ltd; 2025. http://doi:10.1016/j.ejso.2025.110144 PubMed PMID: 40373734. Komada H, Hirota Y, So A, Nakamura T, Okuno Y, Fukuoka H, et al. Insulin Secretion and Insulin Sensitivity Before and After Surgical Treatment of Pheochromocytoma or Paraganglioma. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3400–5. http://doi:10.1210/JC.2017-00357 PubMed PMID: 28666346. Amalia R, Dewi IP, Wardhani LFK, Pikir BS. Cardiovascular Presentation in Pheochromocytoma: What We Should be Aware. Siriraj Med J. 2022 Jan 1;74(1):68–74. http://doi:10.33192/SMJ.2022.9 Gupta PK, Marwaha B. Pheochromocytoma. StatPearls. 2024 Nov 7. PubMed PMID: 36944004. Buscemi S, Di Buono G, D’andrea R, Ricci C, Alberici L, Querci L, et al. Perioperative Management of Pheochromocytoma: From a Dogmatic to a Tailored Approach. J Clin Med. 2021 Aug 2;10(16):3759. http://doi:10.3390/JCM10163759 PubMed PMID: 34442056. Odierna I, Pagano T, Erra A, Oliveri L, Pasquale M, Muoio R, et al. Pheochromocytoma-induced inverted takotsubo cardiomyopathy and cardiogenic shock: case report. Anaesthesiol Intensive Ther. 2022;54(4):341. http://doi:10.5114/AIT.2022.121100 PubMed PMID: 36458670. Wu HY, Gao TJ, Cao YW, Liang L. Case Report: Pheochromocytoma in a 59-Year-Old Woman Presenting With Hypotension. Front Cardiovasc Med. 2021 Mar 11;8:648725. http://doi:10.3389/FCVM.2021.648725/TEXT Akamizu T. Thyroid Storm: A Japanese Perspective. Thyroid. 2018 Jan 1;28(1):32–40. http://doi:10.1089/THY.2017.0243 PubMed PMID: 28899229. Villarraga N, Palani G, Risk M, Sibley S. Unique Presentation and Perioperative Management of a Giant Pheochromocytoma. JCEM Case Reports. 2023 May 8;1(3). http://doi:10.1210/JCEMCR/LUAD065 PubMed PMID: 37908578. Miao J, Hu X, Wang T, Liu F, Zhang D, Wei H. Case Report: Giant pheochromocytoma complicated by takotsubo syndrome: a case of emergency robot-assisted left adrenalectomy and multidisciplinary management. Front Oncol. 2025 Jun 16;15:1603477. http://doi:10.3389/FONC.2025.1603477/TEXT Wu R, Tong N, Chen X, Xu S, Zhang F, Tang L, et al. Pheochromocytoma crisis presenting with hypotension, hemoptysis, and abnormal liver function: A case report. Medicine. 2018 Jun 1;97(25). http://doi:10.1097/MD.0000000000011054 PubMed PMID: 29923996.
Copyrights © 2026